ASSERTIO
Assertio is a specialty pharmaceutical company focused on developing and commercializing products to treat pain and other central nervous system conditions. The company was founded in 1995 and has established itself by developing and incorporating promising technology into differentiated therapeutic products, taking those products through clinical approval, and building a strong market presence. The company currently markets four FDA-approved products, Gralise (gabapentin) tablets for the manage... ment of Postherpetic Neuralgia (PHN), Cambia (diclofenac potassium for oral solution) for the acute treatment of migraine attacks with or without aura in adults 18 years of age or older, Zipsor (diclofenac potassium) liquid-filled capsules for relief of mild to moderate acute pain, and Lazanda (fentanyl) nasal spray CII for the management of breakthrough pain in cancer patients. See Important Safety Information for Gralise, Cambia, Zipsor, and Lazanda.
ASSERTIO
Industry:
Biotechnology Health Care Health Diagnostics Life Science Medical Pharmaceutical
Founded:
1995-01-01
Address:
Lake Forest, Illinois, United States
Country:
United States
Website Url:
http://www.assertiotx.com
Total Employee:
101+
Status:
Active
Contact:
224.419.7106
Total Funding:
1.01 B USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Domain Not Resolving SPF Google Font API Google Tag Manager WordPress Google Analytics Google Maps Content Delivery Network
Similar Organizations
Agilent Technologies
Agilent Technologies addresses the scientific and laboratory management needs of analytical scientists and clinical researchers.
Alixia
Alixia is a medical research company that engages in developing new modalities to treat cancer, aging, and inflammation.
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals is a biopharmaceutical company focused on the discovery, development and commercialization.
AVEO Oncology
AVEO is a biopharmaceutical company that offers drug development strategies for targeted cancer therapeutics.
BioDelivery Sciences
BioDelivery Sciences is a pharmaceutical company that focuses on pain management and addiction medicine.
Peplin
Peplin is a specialty pharmaceutical company focused on advancing and commercializing medical dermatology products.
Sumitomo Pharma America Holdings
Sumitomo Pharma America Holdings supports and enables the discovery, development, and commercialization of treatments to help patients.
Current Advisors List
Board_member
Board_member
2013-07-01
Current Employees Featured
Howard Franklin Senior Vice President @ Assertio
Senior Vice President
2023-01-01
Matthew Gosling Senior Vice President and General Counsel @ Assertio
Senior Vice President and General Counsel
Brendan O'Grady CEO @ Assertio
CEO
2024-05-01
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2023-04-25 | Spectrum Pharmaceuticals | Spectrum Pharmaceuticals acquired by Assertio | N/A |
Investors List
Deerfield
Deerfield investment in Post-IPO Debt - Assertio
Pharmakon Advisors
Pharmakon Advisors investment in Post-IPO Debt - Assertio
Morgan Stanley
Morgan Stanley investment in Post-IPO Debt - Assertio
RBC Capital Markets
RBC Capital Markets investment in Post-IPO Debt - Assertio
Thomas Weisel Partners
Thomas Weisel Partners investment in Post-IPO Equity - Assertio
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2023-01-17 | LGS Foundation | Assertio investment in Grant - LGS Foundation | 100 K USD |
Key Employee Changes
| Date | New article |
|---|---|
| 2024-05-29 | Assertio names Brendan O’Grady as its new CEO |
| 2023-03-06 | Assertio Appoints Dr. Howard Franklin as Senior Vice President, Medical |
Official Site Inspections
http://www.assertiotx.com Semrush global rank: 2.94 M Semrush visits lastest month: 5.4 K
Unable to get host informations!!!
Assertiotx.com lookup results from whois.networksolutions.com server:
- Domain created: 16th-Mar-2018
- Domain updated: 15th-Jan-2025
- Domain expires: 16th-Mar-2028 2 Years, 336 Days left
- Website age: 7 Years, 29 Days
- Registrar Domain ID: 2239635807_DOMAIN_COM-VRSN
- Registrar Url: http://networksolutions.com
- Registrar WHOIS Server: whois.networksolutions.com
- Registrar Abuse Contact Email: domain.operations@web.com
- Registrar Abuse Contact Phone: +1.8777228662
- Name server:
- NS1-04.AZURE-DNS.COM
- NS2-04.AZURE-DNS.NET
- NS3-04.AZURE-DNS.ORG
- NS4-04.AZURE-DNS.INFO
More informations about "Assertio"
Assertio Holdings » Compliance & Ethics
Assertio Holdings, Inc. - Governance - Governance Documents
Investor@assertiotx.com. Investor Email Alerts. To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. After submitting your …See details»
Assertio Holdings » Assertio’s Action Plan
For our company, these truly are exciting times, however the start of our organization comes at a time of incredible turmoil in our country. While we’ve been navigating the impact of Covid-19 …See details»
Assertio - Overview, News & Similar companies | ZoomInfo.com
Feb 17, 2021 Assertio has announced that a new Chief Commercial Officer has joined the organization. Executive Moves, New Hire ... 419-7106 Website: www.assertiotx.com What …See details»
Assertio Holdings, Inc. - Investor Relations
Investor@assertiotx.com. Investor Email Alerts. To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. After submitting your …See details»
Assertio Announces Restructuring Plan and Leadership Changes
Dec 15, 2020 To learn more about Assertio, visit www.assertiotx.com.Investor Contact Lee Roth Burns McClellan for Assertio Holdings, Inc. lroth@burnsmc.com ir@assertiotx.comForward …See details»
Assertio Company Profile | Management and Employees List
SQL International Organization for Standardization . CSS World Wide Web Consortium . Network Hardware (4 Technologies) Cisco Nexus Cisco . Cisco Hardware Cisco . ...See details»
Assertio Company Profile - Office Locations, Competitors, Revenue ...
Oct 29, 2024 Assertio has 5 employees at their 1 location and $152.07 m in annual revenue in FY 2023. See insights on Assertio including office locations, competitors, revenue, financials, …See details»
Assertio Holdings Inc. - Cruelty Free Investing
Company Website: https://www.assertiotx.com Contact: jthomas@assertiotx.com ©2025 CrueltyFreeInvesting.org | Cruelty Free Investing is a registered 501c3 Non-Profit Organization …See details»
Assertio Holdings » Overview
Contact Us 100 South Saunders Road, Suite 300 Lake Forest, IL 60045 Tel: 224.419.7106 Fax: 510.744.8001See details»
Assertio Holdings » Management
Ms. Dir joined Assertio in August 2023 as Vice President, Human Resources and has served as Vice President, Human Resources, IT and Facilities since November 2023. In her current role, …See details»
Assertio Holdings, Inc. - Governance - Committee Composition
Investor@assertiotx.com. Investor Email Alerts. To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. After submitting your …See details»
Assertio Holdings, Inc. (Assertio Holdings, Inc.) - 药物管线_专利_临 …
To learn more about Assertio, visit www.assertiotx.com. Forward Looking Statements Statements in this communication that are not historical facts are forward-looking statements that reflect …See details»
Assertio Holdings » CORPORATE RESPONSIBILITY STATEMENT
Contact Us 100 South Saunders Road, Suite 300 Lake Forest, IL 60045 Tel: 224.419.7106 Fax: 510.744.8001See details»
Assertio Holdings, Inc. - Resources - Investor Contacts
Investor@assertiotx.com. Investor Email Alerts. To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. After submitting your …See details»
Assertio Holdings, Inc. - Financials - SEC Filings
Investor@assertiotx.com. Investor Email Alerts. To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. After submitting your …See details»
Garantex Cryptocurrency Exchange Disrupted in International …
Mar 7, 2025 Garantex Splash Page. In conjunction with the operation targeting Garantex, the Department also announced the unsealing of an indictment in the Eastern District of Virginia …See details»
Assertio Holdings » Board of Directors
Mr. O’Grady, age 57, most recently served as CEO of the Global Formulations Business at Glenmark Pharmaceuticals Ltd. (India: NSE), a multinational pharmaceutical company, from …See details»
Assertio Holdings, Inc. - Financials - Annual Reports
Investor@assertiotx.com. Investor Email Alerts. To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. After submitting your …See details»
Assertio Holdings, Inc. - Events & Presentations
Investor@assertiotx.com. Investor Email Alerts. To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. After submitting your …See details»